Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
News > Business News
Audio By Carbonatix
4:30 PM on Tuesday, December 30
The Associated Press
GENEVA--(BUSINESS WIRE)--Dec 30, 2025--
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.
A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Connect with us on
Facebook
LinkedIn
View source version on businesswire.com:https://www.businesswire.com/news/home/20251229416794/en/
CONTACT: Investor Relations
Daniel Cravens
Allen Trang
+ 41 589 112 110 (Geneva)
+ 1 817 615 2789 (Fort Worth)
[email protected] Relations
Steven Smith
+ 41 589 112 111 (Geneva)
+ 1 817 551 8057 (Fort Worth)
KEYWORD: TEXAS EUROPE SWITZERLAND UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: OPTICAL HEALTH SURGERY MEDICAL DEVICES
SOURCE: Alcon Inc. Investors
Copyright Business Wire 2025.
PUB: 12/30/2025 04:30 PM/DISC: 12/30/2025 04:30 PM
http://www.businesswire.com/news/home/20251229416794/en